Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - REATA PHARMACEUTICALS INC | reta-ex321_6.htm |
EX-31.2 - EX-31.2 - REATA PHARMACEUTICALS INC | reta-ex312_14.htm |
EX-31.1 - EX-31.1 - REATA PHARMACEUTICALS INC | reta-ex311_9.htm |
EX-23.1 - EX-23.1 - REATA PHARMACEUTICALS INC | reta-ex231_13.htm |
EX-21.1 - EX-21.1 - REATA PHARMACEUTICALS INC | reta-ex211_298.htm |
EX-10.38 - EX-10.38 - REATA PHARMACEUTICALS INC | reta-ex1038_1163.htm |
EX-10.37 - EX-10.37 - REATA PHARMACEUTICALS INC | reta-ex1037_1164.htm |
10-K - 10-K - REATA PHARMACEUTICALS INC | reta-10k_20201231.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Reata Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Manmeet S. Soni, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: March 1, 2021 |
|
By: |
|
/s/ Manmeet S. Soni |
|
|
|
|
Manmeet S. Soni |
|
|
|
|
Chief Operating Officer, Chief Financial Officer, and Executive Vice President |
|
|
|
|
(Principal Financial Officer) |